Trimethylammonium

Trimethylammonium

SCHEMBL21743

C=C(C)C(=O)NCCC.CN(C)C

nearest known ligand 0.42

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.42
GAA P10253 1/20 0.42
MAPT P10636 1/20 0.42
RAB9A P51151 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
MMP1 P03956 1/20 0.39
MMP2 P08253 1/20 0.39
MMP3 P08254 1/20 0.39
MMP9 P14780 1/20 0.39
EPHX1 P07099 2/20 0.38
PAOX Q6QHF9 1/20 0.36
MCL1 Q07820 1/20 0.36
CHRNB2 P17787 1/20 0.36
CHRNB4 P30926 1/20 0.36
CHRNA3 P32297 1/20 0.36
CHRNA4 P43681 1/20 0.36
TGFBR1 P36897 1/20 0.34
KDM4C Q9H3R0 1/20 0.34
KDM4E B2RXH2 3/20 0.33
ALDH1A1 P00352 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trimethylammonium SCHEMBL27347511 0.98 NPC1 (0.41) NPC1GAAMAPTRAB9ASMN1; SMN2
Trimethylammonium SCHEMBL635942 0.98 NPC1 (0.41) NPC1GAAMAPTRAB9ASMN1; SMN2
Trimethylammonium SCHEMBL869520 0.98 NPC1 (0.41) NPC1GAAMAPTRAB9ASMN1; SMN2
Trimethylammonium SCHEMBL28199923 0.96 NPC1 (0.40) NPC1GAAMAPTRAB9ASMN1; SMN2
Acetic Acid SCHEMBL9389723 0.94 NPC1 (0.39) NPC1GAAMAPTRAB9ASMN1; SMN2
SCHEMBL149370 0.93
N,N-Dimethylethanaminium SCHEMBL446053 0.92 NPC1 (0.40) NPC1GAAMAPTRAB9ASMN1; SMN2
Hydrochloric Acid SCHEMBL3148805 0.91 MMP1 (0.41) NPC1GAAMAPTRAB9ASMN1; SMN2
Ammonia Solution, Strong SCHEMBL27993992 0.91 MMP1 (0.41) NPC1GAAMAPTRAB9ASMN1; SMN2
Trimethylammonium SCHEMBL3277856 0.91 NPC1 (0.37) NPC1GAAMAPTRAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 652 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260062327-A1 MEMBRANE TREATMENT OF WATER CONTAINING FREE OIL ECOLAB USA INC (US) 2026-03-05 US claimed
US-12454641-B2 Multifunctional wax dispersant for subterranean chemical applications EVONIK OPERATIONS GMBH (DE) 2025-10-28 US claimed
US-12421342-B2 Crosslinkable reactive silicone organic copolymers dispersions WACKER CHEMIE AG (DE) 2025-09-23 US claimed
US-12398367-B2 Use of cationic hydroxyalkyl guars for microorganisms growth SPECIALTY OPERATIONS FRANCE (FR) 2025-08-26 US claimed
US-12359113-B2 Method for dispersing kinetic hydrate inhibitors CHAMPIONX LLC (US) 2025-07-15 US claimed
US-12317899-B2 Agrochemical composition QUÍMIçOS E SOLUCOES SUSTENTÁVEIS DO BRASIL S.A. (BR) 2025-06-03 US claimed
EP-4269530-B1 MULTIFUNCTIONAL WAX DISPERSANT FOR SUBTERRANEAN CHEMICAL APPLICATIONS EVONIK OPERATIONS GMBH (DE) 2024-11-20 EP claimed
CN-118901333-A Plant growth enhancement by use of cationic guar 罗地亚经营管理公司 2024-11-08 CN claimed
EP-4269531-B1 MULTIFUNCTIONAL WAX DISPERSANT FOR SUBTERRANEAN CHEMICAL APPLICATIONS EVONIK OPERATIONS GMBH (DE) 2024-09-11 EP claimed
CN-114501997-B Agrochemical composition 罗地亚巴西有限公司 2024-07-19 CN claimed
US-5925714-A USING ALKOXYLATED CASTOR OIL AS BIODEGRADABLE SURFACTANT RELEASE OR ACTIVATION AGENT FOR INVERSION OF WATER IN OIL EMULSION OF WATER SOLUBLE SUBSTITUTED POLY(METH)ACRYLAMIDES, THICKENERS, FLOCCULATING AGENTS, WASTE WATER TREATMENT SNF S.A. (FR) 1999-07-20 US claimed
US-5412052-A Grafted copolymers highly absorbent to aqueous electrolyte solutions PHILLIPS PETROLEUM COMPANY (US) 1995-05-02 US claimed
US-5334685-A Containing an ampholytic ion pair monomer comprising an ammonium cation 3-methacrylamidopropyltrimethylammonium and a sulfonate anion PHILLIPS PETROLEUM COMPANY (US) 1994-08-02 US claimed
US-5281673-A Polysaccharide graft polymerized with olefinic monomer and ampholytic monomer PHILLIPS PETROLEUM COMPANY (US) 1994-01-25 US claimed
US-5252690-A For aqueous electrolytes PHILLIPS PETROLEUM COMPANY (US) 1993-10-12 US claimed
US-5225506-A Vinyl- and sulfoalkyl-substituted imidazolium monomer; disposable diapers and paper towels PHILLIPS PETROLEUM COMPANY (US) 1993-07-06 US claimed
US-4970260-A Novel viscosifiers for salt-containing solutions based on polymer complexes EXXON RESEARCH AND ENGINEERING COMPANY (US) 1990-11-13 US claimed
US-4584339-A TWO WATER SOLUBLE COPOLYMERS, ONE CONTAINING CATIONIC COMONOMERS, THE OTHER CONTAINING ANIONIC COMONOMERS EXXON RESEARCH AND ENGINEERING CO. (US) 1986-04-22 US claimed
US-4536539-A Dilatant behavior of interpolymer complexes in aqueous solution EXXON RESEARCH AND ENGINEERING CO. (US) 1985-08-20 US claimed
US-4489180-A ANIONIC AND CATIONIC COPOLYMERS EXXON RESEARCH AND ENGINEERING CO. (US) 1984-12-18 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12317899-B2 Agrochemical composition NPM1, PTPRZ1, PEX3 NPC1 2381/4885GAA 96/4885MAPT 1424/4885
US-20260062327-A1 MEMBRANE TREATMENT OF WATER CONTAINING FREE OIL FGB, EPCAM, F8 NPC1 2199/4885GAA 3916/4885MAPT 3070/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.